Ann Intern Med 123 : 747753
Evidence indicates that sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and insulin improve -cell incretin sensitivity in humans
Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, GLP1R, MC4R, and TCF7L2 variants that shape baseline appetite-regulation and energy-balance biology
By week 68, the majority of users experience significant relief, though some continue to notice mild bloating when they eat larger meals or consume trigger foods
It may also be less suitable for individuals who want access to a wider range of medication options beyond what is available through compounded treatments
Strengthening this view, Notch deficiency was shown to lead to hypertrophy and fibrosis in the mouse heart 60